How We Help Founders And Investors
Great laboratory science is only half the battle. To successfully scale up, you need a realistic path that covers manufacturing realities and strict global regulations.
We provide hands-on, part-time R&D and business strategy to help you clean up preclinical data, avoid costly errors before tech transfers, and prepare for investor due diligence. You get senior expertise right when your milestones require it, without taking on the heavy cost of a permanent executive payroll too early.
Investor Pitch Decks & Fundraising:Translating complex molecular biology and technical milestones into a clear, high-value business narrative to secure institutional capital.
Asset Evaluation & Due Diligence: Auditing early-stage laboratory platforms, data packages, and molecule feasibility to protect investor capital before a deal closes.
Capital Preparation and Due-Diligence
R&D Strategy & De-Risking: Defining clear research directions, evaluating platform feasibility, and setting realistic development timelines to protect your financial runway.
Scale-Up & IND Readiness: Guiding complex biologics programs from early discovery through the physical CDMO development steps required for IND submission.
Preclinical Development and Operations
Global Scaling and IP Protection
APAC Market Entry & Hub Incubation:Identifying high-growth Asia-Pacific opportunities and securing fast-track placement into premier biotech hubs like HKSTP and Singapore frameworks.
IP Portfolio Strategy: Authoring defensible patent applications and building protective, cross-border asset portfolios from the ground up.
Ready to Accelerate Your Pipeline?
If you want to de-risk your technology, evaluate a potential life science investment, or map out your next cross-border R&D milestone, let's connect.